Mangalam Drugs

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE584F01014
NSEID: MANGALAM
BSEID: 532637

INR

75.50

0.85 (1.14%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 8.82 k

Click here to access the older version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Divi's Lab.

Cipla

Samrat Pharma

Sun Pharma.Inds.

Torrent Pharma

Source Natural

Mangalam Drugs

Mankind Pharma

Ajooni Biotech

Vaidya Sane

Onyx Biotec

Why is Mangalam Drugs and Organics Ltd ?

Weak Long Term Fundamental Strength with a 19.24% CAGR growth in Operating Profits over the last 5 years

Stock is technically in a Bearish range

The technical trend has deteriorated from Mildly Bearish on 28-Feb-25 and has generated -17.67% returns since then
Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -25.75% returns in the last 1 year, the stock has also underperformed BSE 500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Mangalam Drugs for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Mangalam Drugs

-25.75%

-0.50

51.69%

SENSEX

0.45%

0.03

14.48%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

7.47%

EBIT Growth (5y)

19.24%

EBIT to Interest (avg)

2.17

Debt to EBITDA (avg)

3.70

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

1.77

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

Pledged Shares

11.01%

Institutional Holding

0.11%

ROCE (avg)

11.47%

ROE (avg)

10.09%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.80

EV to EBIT

8.99

EV to EBITDA

5.23

EV to Capital Employed

0.87

EV to Sales

0.56

PEG Ratio

0.07

Dividend Yield

ROCE (Latest)

9.01%

ROE (Latest)

7.00%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

Mildly Bearish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company

PAT(9M)

Higher at Rs 6.77 Cr

-3What is not working for the Company

PAT(Q)

At Rs 1.29 cr has Fallen at -45.1% (vs previous 4Q average

Loading Valuation Snapshot...

Here's what is not working for Mangalam Drugs

Profit After Tax (PAT) - Quarterly

At Rs 1.29 cr has Fallen at -45.1% (vs previous 4Q average)

over average PAT of the previous four quarters of Rs 2.35 Cr

MOJO Watch

Near term PAT trend is very negative

PAT (Rs Cr)